Vinigrol

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 585389

CAS#: 111025-83-3

Description: Vinigrol is an antihypertensive and platelet aggregation inhibitory agent produced by a fungus, Virgaria nigra. II.


Chemical Structure

img
Vinigrol
CAS# 111025-83-3

Theoretical Analysis

MedKoo Cat#: 585389
Name: Vinigrol
CAS#: 111025-83-3
Chemical Formula: C20H34O3
Exact Mass: 322.25
Molecular Weight: 322.489
Elemental Analysis: C, 74.49; H, 10.63; O, 14.88

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Vinigrol; Antibiotic FR 900478

IUPAC/Chemical Name: (1S,2R,5S,6S,9S,10R,13S,14S)-12-(hydroxymethyl)-2,9-dimethyl-6-propan-2-yltricyclo[8.4.0.05,14]tetradec-11-ene-1,13-diol

InChi Key: UADXIAKXDDMQEN-VGZBWQSVSA-N

InChi Code: InChI=1S/C20H34O3/c1-11(2)15-7-5-12(3)17-9-14(10-21)19(22)18-16(15)8-6-13(4)20(17,18)23/h9,11-13,15-19,21-23H,5-8,10H2,1-4H3/t12-,13+,15-,16-,17-,18-,19+,20-/m0/s1

SMILES Code: O[C@@]12[C@H](C)CC[C@@]3([H])[C@H](C(C)C)CC[C@H](C)[C@]1([H])C=C(CO)[C@@H](O)[C@@]23[H]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 322.49 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Draghici C, Njardarson JT. Synthetic Approaches and Total Syntheses of Vinigrol, a Unique Diterpenoid. Tetrahedron. 2015 Jun 10;71(23):3775-3793. PubMed PMID: 26034329; PubMed Central PMCID: PMC4447714.

2: Yu X, Xiao L, Wang Z, Luo T. Scalable Total Synthesis of (-)-Vinigrol. J Am Chem Soc. 2019 Feb 27;141(8):3440-3443. doi: 10.1021/jacs.9b00621. Epub 2019 Feb 18. PubMed PMID: 30767520.

3: Min L, Lin X, Li CC. Asymmetric Total Synthesis of (-)-Vinigrol. J Am Chem Soc. 2019 Oct 9;141(40):15773-15778. doi: 10.1021/jacs.9b08983. Epub 2019 Sep 30. PubMed PMID: 31545036.

4: Ando T, Yoshida K, Okuhara M. Vinigrol, a novel antihypertensive and platelet aggregation inhibitory agent produced by a fungus, Virgaria nigra. II. Pharmacological characteristics. J Antibiot (Tokyo). 1988 Jan;41(1):31-5. PubMed PMID: 2831182.

5: Betkekar VV, Sayyad AA, Kaliappan KP. A domino enyne/IMDA approach to the core structure of (-) vinigrol. Org Lett. 2014 Nov 7;16(21):5540-3. doi: 10.1021/ol502497n. Epub 2014 Oct 13. PubMed PMID: 25310274.

6: Morton JG, Draghici C, Kwon LD, Njardarson JT. Rapid assembly of vinigrol's unique carbocyclic skeleton. Org Lett. 2009 Oct 15;11(20):4492-5. doi: 10.1021/ol901519k. PubMed PMID: 19728692; PubMed Central PMCID: PMC2759413.

7: Paquette LA, Efremov I. Exploratory studies aimed at a synthesis of vinigrol. 3. Evaluation of a lactone bridge as a conformational lock. J Org Chem. 2005 Jan 21;70(2):510-3. PubMed PMID: 15651794.

8: Yang Q, Njardarson JT, Draghici C, Li F. Total synthesis of vinigrol. Angew Chem Int Ed Engl. 2013 Aug 12;52(33):8648-51. doi: 10.1002/anie.201304624. Epub 2013 Jul 1. PubMed PMID: 23818094; PubMed Central PMCID: PMC3805134.

9: Yang Q, Draghici C, Njardarson JT, Li F, Smith BR, Das P. Evolution of an oxidative dearomatization enabled total synthesis of vinigrol. Org Biomol Chem. 2014 Jan 14;12(2):330-44. doi: 10.1039/c3ob42191k. PubMed PMID: 24258093; PubMed Central PMCID: PMC3901359.

10: Maimone TJ, Shi J, Ashida S, Baran PS. Total synthesis of vinigrol. J Am Chem Soc. 2009 Dec 2;131(47):17066-7. doi: 10.1021/ja908194b. PubMed PMID: 19877628; PubMed Central PMCID: PMC2787793.

11: Huters AD, Garg NK. Synthetic studies inspired by vinigrol. Chemistry. 2010 Aug 2;16(29):8586-95. doi: 10.1002/chem.201000916. Review. PubMed PMID: 20602369.

12: Wang XL, Lu YY, Wang J, Wang X, Yao HQ, Lin GQ, Sun BF. A novel synthetic approach to the bicyclo[5.3.1]undecan-11-one framework of vinigrol. Org Biomol Chem. 2014 Jun 14;12(22):3562-6. doi: 10.1039/c4ob00046c. Epub 2014 Mar 28. PubMed PMID: 24676561.

13: Grisé CM, Tessier G, Barriault L. Synthesis of the tricyclic core of vinigrol via an intramolecular Diels-Alder reaction. Org Lett. 2007 Apr 12;9(8):1545-8. Epub 2007 Mar 16. PubMed PMID: 17362025.

14: Paquette LA, Efremov I, Liu Z. Exploratory studies aimed at a synthesis of vinigrol. 2. Attempts to exploit ring-closing metathesis for construction of the central cyclooctane belt. J Org Chem. 2005 Jan 21;70(2):505-9. PubMed PMID: 15651793.

15: Souweha MS, Enright GD, Fallis AG. Vinigrol: a compact, diene-transmissive Diels-Alder strategy to the tricyclic core. Org Lett. 2007 Dec 6;9(25):5163-6. Epub 2007 Nov 14. PubMed PMID: 17999510.

16: Ando T, Tsurumi Y, Ohata N, Uchida I, Yoshida K, Okuhara M. Vinigrol, a novel antihypertensive and platelet aggregation inhibitory agent produced by a fungus, Virgaria nigra. I. Taxonomy, fermentation, isolation, physicochemical and biological properties. J Antibiot (Tokyo). 1988 Jan;41(1):25-30. PubMed PMID: 3346190.

17: Paquette LA, Liu Z, Efremov I. Exploratory studies aimed at a synthesis of vinigrol. 4. Probe of possible means for direct connection of the side arms and of ring-contraction alternatives. J Org Chem. 2005 Jan 21;70(2):514-8. PubMed PMID: 15651795.

18: Gentric L, Le Goff X, Ricard L, Hanna I. Toward the total synthesis of vinigrol: synthesis of epi-C-8-dihydrovinigrol. J Org Chem. 2009 Dec 18;74(24):9337-44. doi: 10.1021/jo901971f. PubMed PMID: 19911847.

19: Poulin J, Grisé-Bard CM, Barriault L. A formal synthesis of vinigrol. Angew Chem Int Ed Engl. 2012 Feb 27;51(9):2111-4. doi: 10.1002/anie.201108779. Epub 2012 Jan 19. PubMed PMID: 22259041.

20: Maimone TJ, Voica AF, Baran PS. A concise approach to vinigrol. Angew Chem Int Ed Engl. 2008;47(16):3054-6. doi: 10.1002/anie.200800167. PubMed PMID: 18338349.